Creation and Implementation of a Multidisciplinary Pediatric Hematopoietic Stem Cell Transplant Discharge

Jessica D Murphy1, Kathryn Duke2, Cambree J Fillis2

  • 1School of Nursing, Johns Hopkins University, Baltimore, MD 21205, USA.

PubMed

Insights

Developing a new discharge program for pediatric hematopoietic stem cell transplant (HSCT) patients improved team communication and organization. Further research is needed to establish best practices for caregiver readiness in HSCT care.

Area of Science:

  • Pediatric Hematology/Oncology
  • Stem Cell Transplantation
  • Healthcare Quality Improvement

Background:

  • Pediatric hematopoietic stem cell transplant (HSCT) discharge is complex, with medically fragile, immunocompromised patients requiring precise medication management.
  • Current literature on best practices for pediatric HSCT discharge coordination is scarce.
  • Lack of a standardized discharge process increases risks for patients and caregivers.

Purpose of the Study:

  • To develop and implement a multidisciplinary care coordination program for pediatric HSCT patients post-discharge.
  • To standardize the discharge process and enhance caregiver readiness.
  • To address the scarcity of data on HSCT discharge best practices.

Main Methods:

  • A multidisciplinary team (physicians, APNs, RNs, pharmacists) designed the program.
  • Interventions included standardized education, an EMR-integrated checklist, a 24-hour rooming-in period, and pharmacist follow-up.
  • Caregiver surveys assessed discharge readiness and medication adherence.

Main Results:

  • The program was successfully implemented for 12 patients, demonstrating feasibility.
  • No statistically significant difference in perceived caregiver readiness was found compared to a pre-implementation group.
  • While medication adherence was unevaluable, the medical team anecdotally noted improved organization, collaboration, and communication.

Conclusions:

  • A novel pediatric HSCT discharge coordination program was successfully developed and implemented.
  • The program showed anecdotal clinical significance in improving care team dynamics.
  • Further research is essential to establish evidence-based best practices for pediatric HSCT discharge.

Related Concept Videos

Discharge Summary Forms01:31

Discharge Summary Forms

The discharge summary is crucial as it enables a smooth transition from a healthcare facility to a patient's home or another care setting. This critical document facilitates seamless continuity of care, ensuring patients receive the necessary support and attention.
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
828
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
507
Lineage Commitment01:21

Lineage Commitment

Commitment is the  process whereby stem cells:
3.2K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.2K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.3K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K